Chromosome 7p11.2 (EGFR) variation influences glioma risk
Open Access
- 29 April 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 20 (14) , 2897-2904
- https://doi.org/10.1093/hmg/ddr192
Abstract
While gliomas are the most common primary brain tumors, their etiology is largely unknown. To identify novel risk loci for glioma, we conducted genome-wide association (GWA) analysis of two case–control series from France and Germany (2269 cases and 2500 controls). Pooling these data with previously reported UK and US GWA studies provided data on 4147 glioma cases and 7435 controls genotyped for 424 460 common tagging single-nucleotide polymorphisms. Using these data, we demonstrate two statistically independent associations between glioma and rs11979158 and rs2252586, at 7p11.2 which encompasses the EGFR gene (population-corrected statistics, Pc = 7.72 × 10−8 and 2.09 × 10−8, respectively). Both associations were independent of tumor subtype, and were independent of EGFR amplification, p16INK4a deletion and IDH1 mutation status in tumors; compatible with driver effects of the variants on glioma development. These findings show that variation in 7p11.2 is a determinant of inherited glioma risk.Keywords
This publication has 27 references indexed in Scilit:
- Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityNature Genetics, 2009
- The EGFRvIII variant in glioblastoma multiformeJournal of Clinical Neuroscience, 2009
- Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and NorwayThe Lancet Oncology, 2009
- Epidermal growth factor receptor extracellular domain mutations in primary glioblastomaNeuropathology and Applied Neurobiology, 2009
- Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology ConsortiumCancer, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiformeNeuro-Oncology, 2008
- BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomasInternational Journal of Cancer, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular DomainPLoS Medicine, 2006